Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 1918996)

Published in J Immunol on November 01, 1991

Authors

C V Harding1, D S Collins, O Kanagawa, E R Unanue

Author Affiliations

1: Washington University School of Medicine, Department of Pathology, St. Louis, MO 63110.

Articles citing this

Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol (1992) 1.86

Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect Immun (2004) 1.37

Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A (2009) 1.29

Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials. Br J Haematol (2008) 1.04

Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J Virol (1993) 1.04

Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J Exp Med (1994) 1.02

Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci U S A (1992) 1.00

Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing. J Exp Med (1995) 1.00

Physiological functions of endosomal proteolysis. Biochem J (1995) 0.97

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma. Blood (2007) 0.89

The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies. Clin Exp Immunol (1994) 0.85

A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials (2013) 0.83

Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells. Immunology (2007) 0.81

Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infect Immun (1993) 0.81

Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity. Immunology (1994) 0.80

Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells. Immune Netw (2010) 0.78

Cordyceps militaris Enhances MHC-restricted Antigen Presentation via the Induced Expression of MHC Molecules and Production of Cytokines. Immune Netw (2010) 0.78

Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules. Immunology (1996) 0.78

Use of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assays. Clin Diagn Lab Immunol (1994) 0.75

Vanilloid Receptor 1 Agonists, Capsaicin and Resiniferatoxin, Enhance MHC Class I-restricted Viral Antigen Presentation in Virus-infected Dendritic Cells. Immune Netw (2016) 0.75

Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs. Biomol Ther (Seoul) (2013) 0.75

Articles by these authors

Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39

Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25

Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell (1991) 8.13

Antigen-presenting function of the macrophage. Annu Rev Immunol (1984) 7.83

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78

Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43

Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30

Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 5.22

Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01

Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 4.85

The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol (1981) 4.72

Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70

The regulatory role of macrophages in antigenic stimulation. Adv Immunol (1972) 4.69

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59

The basis for the immunoregulatory role of macrophages and other accessory cells. Science (1987) 4.51

Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18

Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18

Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol (1981) 3.94

Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83

Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83

Activated macrophages induce vascular proliferation. Nature (1977) 3.74

Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68

Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61

A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55

Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50

Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev (1991) 3.49

Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. J Immunol (1980) 3.46

Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol (1984) 3.41

Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39

Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun (1993) 3.38

The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med (1989) 3.30

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science (1990) 3.26

Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09

Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 3.08

A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02

Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. J Immunol (1979) 2.93

Persistence of immunogenicity of antigen after uptake by macrophages. J Exp Med (1968) 2.93

Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89

Monoclonal antibodies specific to native murine T-cell receptor gamma delta: analysis of gamma delta T cells during thymic ontogeny and in peripheral lymphoid organs. Proc Natl Acad Sci U S A (1989) 2.79

Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73

The costimulatory function of antigen-presenting cells. Immunol Today (1990) 2.71

The binding of clathrin triskelions to membranes from coated vesicles. Cell (1981) 2.70

The immune response of mice to antigen in macrophages. Immunology (1968) 2.67

An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65

Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol (1978) 2.54

The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis. J Exp Med (1975) 2.54

Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54

Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51

Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties. J Exp Med (1972) 2.49

Antigen binding and capping by lymphocytes of genetic nonresponder mice. J Exp Med (1972) 2.46

The regulation of lymphocyte functions by the macrophage. Immunol Rev (1978) 2.43

Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 2.40

Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med (1980) 2.38

Hybrid antibodies can target sites for attack by T cells. Nature (1985) 2.36

Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci U S A (1988) 2.26

Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature (1990) 2.23

T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A (1988) 2.21

Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18

Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol (1981) 2.18

Secretory function of mononuclear phagocytes: a review. Am J Pathol (1976) 2.12

An inhibitor of cell proliferation released by cultures of macrophages. Proc Natl Acad Sci U S A (1974) 2.11

Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol (1991) 2.08

The immunogenicity of antigen bound to the plasma membrane of macrophages. J Exp Med (1970) 2.08

Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med (1973) 2.08

A defect in the antigen-presenting function of macrophages from neonatal mice. Nature (1979) 2.07

Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc Natl Acad Sci U S A (1992) 2.06

A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06

Dissociation of antigenicity and immunogenicity of neonatal epidermal allografts in the mouse. Transplantation (1990) 2.05

Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature (1975) 2.04

Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature (1994) 2.02

Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. J Immunol (1979) 2.00

An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (1989) 1.97

Immunity to Listeria infection. Curr Opin Immunol (2000) 1.97

The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. J Exp Med (1979) 1.97

Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J Immunol (1999) 1.96

T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature (1989) 1.95

Persistence of antigen on the surface of macrophages. Nature (1969) 1.95

Distribution of actin in spreading macrophages: a comparative study on living and fixed cells. J Cell Biol (1983) 1.95

Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol (1996) 1.94

Properties and some uses of anti-macrophage antibodies. Nature (1968) 1.94

Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science (1995) 1.93

Different gamma delta T-cell receptors are expressed on thymocytes at different stages of development. Proc Natl Acad Sci U S A (1989) 1.91

Receptor-mediated inactivation of early B lymphocytes. Nature (1975) 1.90

Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens. J Exp Med (1967) 1.90

Redistribution and fate of Ig complexes on surface of B lymphocytes: functional implications and mechanisms. Transplant Rev (1973) 1.88

IA antigens and antigen-presenting function of thymic macrophages. J Immunol (1980) 1.87

The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol (1996) 1.87

Intracellular antibody neutralizes Listeria growth. Immunity (2001) 1.86

Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function. J Immunol (1989) 1.84

Recognition of a self major histocompatibility complex TL region product by gamma delta T-cell receptors. Proc Natl Acad Sci U S A (1989) 1.84

Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration. J Immunol (1975) 1.82

Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity (1997) 1.82

Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell (1991) 1.81

Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. J Immunol (1982) 1.80

Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. J Immunol (1974) 1.79